Out-of-Hospital Management of Diabetic Emergencies in Germany: Structural and Process Quality

Abstract

Aims To collect and analyse representative data of structural and process quality in the management of diabetic emergencies in Germany in 2020.

Methods A standardised questionnaire comprising detailed items concerning clinically relevant parameters on the structural and process quality of out-of-hospital management of diabetic emergencies was sent nationwide to medical directors of emergency medical service districts (EMSDs). Results were compared with those from a similar study conducted in 2001.

Results The return rate of the questionnaires represented 126 EMSDs, serving a total population of > 40.1 million. Only 4% of ambulances carried glucagon (6% in 2001). In 2020, blood glucose determination increased significantly to 71% of all emergency interventions and to 29% of suspected cardiac emergencies (24% and 15%, respectively, in 2001). In 100% of EMSDs severe hypoglycaemia (SH) was treated by paramedics by administering intravenous dextrose before the arrival of a doctor compared to 63% in 2001. The potential value of nasal glucagon was acknowledged by 43% of responders. In selected patients, treatment of SH was conducted without hospital admission in 78% of EMDs (60% in 2001). Fifty-three percent of medical directors acknowledged the need for further training in diabetic emergencies (47% in 2001). Cooperation for medical education between emergency teams and a diabetes centre was reported by 14% (41% in 2001).

Conclusion Structural and process quality of the management of diabetic emergencies in Germany has improved considerably since 2001. Persisting deficiencies could be improved by providing better medical equipment in ambulances and ongoing education to the entire emergency teams.

Key words

Diabetes - emergency medicine - severe hypoglycaemia - process quality - structural quality

Publication History

Received: 11 March 2021
Received: 03 May 2021

Accepted: 28 May 2021

Article published online:
20 July 2021

• References

• 1 Frier BM. Hypoglycaemia in diabetes mellitus: Epidemiology and clinical implications. Nat Rev Endocrinol 2014; 10: 711-722
• 2 Marchesini G, Veronese G, Forlani G. et al. The management of severe hypoglycemia by the emergency system: The HYPOTHESIS study. Nutr Metab Cardiovasc Dis 2014; 24: 1181-1188
• 3 Goto A, Ahra OA, Goto M. et al. Severe hypoglycaemia and cardiovascular disease: Systematic review and meta-analysis with bias analysis. Br Med J 2013; 347: f4533 doi:10.1136/bmj.f4533
• 4 Seaquist ER, Anderson J, Childs B. et al. Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013; 36: 1384-1395
• 5 Budnitz DS, Lovegrove MC, Shehab N. et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002-2012
• 6 Villani M, deCourten B, Zoungas S. et al. Emergency treatment of hypoglycaemia: A guideline and evidence review. Diabet Med 2017; 34: 1205-1211
• 7 Holstein A, Plaschke A, Schlieker H. et al. Structural and process quality in the management of diabetic emergencies in Germany. Int J Qual Health Care 2002; 14: 33-38
• 8 Statistisches Bundesamt Population level 30.06. 2020 https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Bevoelkerungsstand/Tabellen/zensus-geschlecht-staatsangehoerigkeit-2020.html
• 9 R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria 2020; https://www.R-project.org/
• 10 GOVDATA. Federal Agency for Cartography and Geodesy Section GDL2. Service centre (DLZ). Central Office for Geotopography (ZSGT), Leipzig. Administrative Areas 1:000, VG250 and VG250-EW
• 11 Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycaemia: a prospective population-based study. Exp Clin Endocrinol Diabetes 2003; 111: 364-369
• 12 Villani M, Earnest A, Smith K. et al. Outcomes of people with severe hypoglycaemia requiring prehospital emergency medical services management: a prospective study. Diabetologia 2019; 62: 1868-1879
• 13 Fitzpatrick D, Duncan EAS. Improving post-hypoglycaemic patient safety in the prehospital environment: A systematic review. Emerg Med J 2009; 26: 472-478
• 14 Patrick A, Collier A, Hepburn D. et al. Comparison of intramuscular glucagon and intravenous dextrose in the treatment of hypoglycaemic coma in an accident and emergency department. Arch Emerg Med 1990; 7: 73-77
• 15 Thieu VT, Mitchell BD, Varnado OJ. et al. Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon. Diabetes Obes Metab 2020; 22: 469-479
• 16 Pontiroli AE, Tagliabue E. Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: Systematic review and meta-analysis. Acta Diabetol 2020; 57: 743-749
• 17 Fayfman M, Pasquel FP, Umpierrez GE. Management of hyperglycemic crises: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am 2017; 101: 587-606
• 18 International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: Epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol 2019; 7: 385-396
• 19 Deutsche Diabetes Gesellschaft. Therapie des Typ-1-Diabetes. Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-013; 2. Aufl.). Diabetologie 2020; 15 : S40-S50
• 20 Kiefer MV, Hern HG, Alter HJ. et al. Dextrose 10% in the treatment of out-of-hospital hypoglycemia. Prehosp Disaster Med 2014; 29: 190-194
• 21 Holstein A, Plaschke A, Vogel M-Y. et al. Prehospital management of diabetic emergencies – a population-based intervention study. Acta Anaesth Scand 2003; 47: 610-615
• 22 Anderson S, Hogskilde PD, Wetterslev J. et al. Appropriateness of leaving emergency medical service treated hypoglycemic patients at home: a retrospective study. Acta Anaesth Scand 2002; 46: 464-468
• 23 Leese GP, Wang J, Broomhall J. et al. Frequency of severe hypoglycemia requiring emergency medical treatment in type 1 and type 2 diabetes: a population based study of health service resource use. Diabetes Care 2003; 26: 1176-1180
• 24 Müller N, Lehmann T, Klöss A. et al. Changes in incidence of severe hypoglycaemia in people with type 2 diabetes from 2006 to 2016: Analysis based on health insurance data in Germany considering the anti-hyperglycaemic medication. Diabet Med 2020; 37: 1326-1332
• 25 Wang H, Donnan PT, Leese CJ. et al. Temporal changes in frequency of severe hypoglycemia treated by emergency medical services in types 1 and type 2 diabetes: a population-based data-linkage cohort study. Clin Diabetes Endocrinol 2017; 3: 7
• 26 Van Beers CA, DeVries JH, Kleijer SJ. et al. Continuous Glucose Monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): A randomized, open-label, crossover trial. Lancet Diabetes Endocrinol 2016; 4: 893-902
• 27 Heinemann L, Freckmann G, Ehrmann D. et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): A multicenter, randomized controlled trial. Lancet 2018; 391: 1367-1377
• 28 Bolinder J, Antuna R, Geehoed-Duijvestin P. et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: A multicentre, non-masked, randomized controlled trial. Lancet 2016; 388: 2254-2263
• 29 Deshmukh HA, Wilmot EG, Gregory R. et al. Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit. Diabetes Care 2020; 43: 2153-2160